NASDAQ$UPB
Upstream Bio Inc · Q2 2025 earnings
Q2 2025 earnings ·
Briefing
UPB Q2 2025 — $900K revenue
These statements relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, per. Upstream Bio Inc reported Q2 2025 results. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $900K.
- Operating income: $44K.
- Filed on Form 10-Q (accession 0000950170-25-103534).
Headline financials
Revenue & EPS history
Upstream Bio Inc · Revenue · Quarterly
$937K
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q2 2025
+0.8%
Avg return
Earnings day
-2.0%
Avg return
5 days after
+4.5%
Avg return
30 days after
67%
4 / 6 earnings
Positive
+7.9%
Q2 2025
Best reaction
-5.4%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +0.5% | -8.4% | — | |
| Q1 2026 | +4.7% | -5.3% | -31.9% | |
| Q3 2025 | -4.3% | -6.2% | +10.8% | |
| Q2 2025 | +7.9% | +7.0% | +28.8% | |
| Q1 2025 | -5.4% | +1.6% | +24.8% | |
| Q3 2024 | +1.7% | -0.7% | -10.3% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro